The immunopathology of human T cell lymphotropic virus type 1 (HTLV-I) uveitis was addressed by using T cell clones (TCC) established from the intraocular fluid of patients with HTLV-I uveitis. Proviral DNA of HTLV-I was identified in 55 out of 94 (59%) or 13 out of 36 (36%) TCC from the ocular fluid or the peripheral blood of these patients, respectively. Most of HTLV-I-infected TCC had a CD3+ CD4+ CD8-phenotype. HTLV-I infection on TCC was confirmed by analysis of the viral mRNA, nucleotide sequence, virusassociated proteins, and virus particles. HTLV-I-infected TCC, but not HTLV-I negative TCC, constitutively produced high amounts of (1,336±1,050 pg/ml) and TNFa (289±237 pg/ml) in the absence of any stimuli. HTLV-I-infected TCC from the ocular lesion also constitutively produced high amounts of IL-la (12,699 pg/ml), IL-2 (61 pg/ml), IL-3 (428 pglml), (1,268 pg/ml), IL-10 (28 pg/ ml), IFN-y (5,095 pg/ml), and GM-CSF (2,886 pg/ml). Hydrocortisone, a drug effective in vivo for the treatment of HTLV-I uveitis, severely depressed cytokine production in vitro in most cases. In summary, the results demonstrated direct evidence of HTLV-I infection of the eye and suggest that cytokines produced by HTLV-I-infected T cells are responsible for the intraocular inflammation in patients with HTLV-I uveitis. (J. Clin. Invest. 1995. 95:852-858.)
Introduction
Human T cell lymphotropic virus type 1 (HTLV-I)l (1, 2) is a retrovirus endemic to some regions of the globe and causatively associated with adult T cell leukemia (3) and HTLV-I myelopathy (4, 5) . We reported a new disease entity, HTLV-I uveitis, based on seroepidemiological, ophthalmological, and virologi-cal studies in an HTLV-I endemic area in southwest Japan (6 10 ). These studies demonstrated that: (a) the seroprevalence of HTLV-I in patients with idiopathic uveitis was significantly higher than that in patients with uveitis with defined etiology or that in patients with non-uveitic ocular diseases; (b) the ocular manifestations of HTLV-I uveitis were characterized by moderate to severe vitreous opacities with mild iritis and mild retinal vasculitis; and (c) the proviral DNA of HTLV-I was detected by PCR method in cells from the aqueous humor.
However, there have been no reports showing direct evidence that either HTLV-I associated proteins or HTLV-I viral particles are present in the T cells of inflammatory eye lesions of patients with HTLV-I uveitis, primarily due to the limited number of cells available from the eye. Subsequently, the immunopathology of HTLV-I uveitis is yet to be addressed. In this study, we have expanded T cells in vitro from the intraocular fluid of patients with HTLV-I uveitis and characterized HTLV-I infection and cytokine production by these T cells to understand the immunopathogenic mechanisms of the disease.
Methods

Materials
The following is a brief clinical history of the three patients whose intraocular fluid (aqueous and/or vitreous humor) and PBMC were used in this study. Informed consent was given by these patients before the samples were obtained. The research followed the tenets of the Declaration of Helsinki. The cells showing a uniform T cell phenotype (i.e., a CD3+ CD4+ CD8-or a CD3+ CD4-CD8+ phenotype) were considered potential T cell clones (TCC) and were used in this study. The clonality of these potential TCC was investigated by sequencing T cell receptor a and /B genes, and the majority of them used a single T cell receptor as reported previously (13) .
Patient 1 (HTLV-I uveitis
Detection ofproviral DNA of the HTLV-I tax gene 2 j1i of 2 X 106 cells per ml cell suspension was added to 20 jil of the lysing buffer (2% Triton X-100 buffer and 10 mM Tris-HCl, pH 9.3), and was vortexed for 30 s. Proviral DNA for the HTLV-I tax gene was amplified using the PCR method and the following tax gene specific primers: 5'-CGGATACCCAGTCTACGTGT-3' (forward primer, nucleotide positions 7336-7355) and 5'-GAGCCGATAACGCGTCCA-TCG-3' (reverse primer, nucleotide position 7494-7474) (Takara Shuzo, Kyoto, Japan). The products were subjected to PCR in the presence of the primers (1 pmol), 200 mM deoxynucleotide triphosphates, and 2.5 U of Taq polymerase in a buffer containing 50 mM KCl and 1.5 mM MgCl2. Samples were subjected to 35 cycles of amplification consisting of denaturation for 1 min at 94°C, annealing for 1 min at 53°C, and polymerization for 1 min at 72°C. The PCR products were analyzed using agarose gel electrophoresis and ethidium bromide staining.
Detection of HTLV-I gene expression at the mRNA level and nucleotide sequencing Total RNA was harvested by lysis of 1 x 107 cells using RNAzols B (Biotec Laboratories, Inc., Houston, TX) according to the manufacturer's instruction. 3 mg of total RNA was mixed with random hexamers (GIBCO BRL, Gaithersburg, MD) and SuperScript-reverse transcriptaseQD (GIBCO BRL) and incubated at 37°C for 60 min to obtain cDNA.
The cDNA was then subjected to PCR as described above in the presence of 1 pmol of tax gene primers (forward primer: 5'-CAGGAGGCTCTC-CAAGAAGCT-3', reverse primer: 5'-AAACACGTAGACTGGGTA-TCC-3') or env gene primers (forward primer: 5'-TGTGGTGCCTCC-TGAACTGCG-3', reverse primer: 5'-CAGCAGCTGGGGCTGTAA-TCA-3'). The amplified product of the cDNA tax gene was also cloned using TA cloning system (Invitrogen, San Diego, CA) followed by cDNA sequencing with an Auto Read" sequencing kit and auto DNA sequencer (Pharmacia AB, Uppsala, Sweden) according to the manufacturers' instructions.
Detection of HTLV-I associated proteins
HTLV-I proteins were examined on the cells by immunofluorescence technique using MET-3 mAb (anti-env gp46) (14) Cytokine assay TCC were washed twice with RPMI 1640 medium and then were cultivated at 1 x 106/ml in the medium with 10% FCS alone in 24-well tissue culture plates for 20 h. Cell-free culture supernatants were obtained by centrifugation of the cells and stored at -80'C until use. The ELISA kits used to detect cytokines were: IL-6 kit (sensitivity > 5 pg/ml; Immunotech, Marseilles, France), TNF-a kit (> 5 pg/ml; Immunotech), IL-la kit (> 3 pg/ml; Cayman Chemical Co., Inc., Ann Arbor, MI), IFN-y kit (> 5 pg/ml; Endogen, Inc., Boston, MA), IL-2 (> 9 pg/ml; Biosource International, Camarillo, CA), IL-10 (> 5 pg/ml; Biosource International), GM-CSF (> 2 pg/ml; R&D Systems, Inc., Minneapolis, MN), IL-3 (> 8 pg/ml; R&D Systems, Inc.), and IL-4 (> 3 pg/ml; Amersham Life Science, Tokyo, Japan). IL-8 was also measured by a kit kindly provided by Dr. N. Mukaida (Kanazawa University, Kanazawa, Japan) as reported previously (sensitivity > 16 pg/ml) (19 Fig. 1 and P16 ; data not shown). All of them expressed HLA-DR antigens except the CD19 B cell antigen. 5 of 11 TCC (4 HTLV-I provirus+ and 1 HTLV-I provirus-) expressed CD25 (IL-2Ra) antigens, while none of them showed CD 122 (IL-2R,/) antigen. The majority of TCC from patient 3 with Behcet's disease also had a CD3+ CD4+ CD8-phenotype.
HTLV-I infection at the mRNA and protein levels. All HTLV-I provirus+ TCC tested strongly expressed both env and tax genes at the mRNA level. Representative results are shown in the third and fourth lanes of Fig. 1 . HTLV-I provirus-TCC failed to express these genes (Fig. 1) . cDNA from a portion of the tax gene (from position 5029 to position 7357) was sequenced. The cDNA from two different HTLV-I-infected TCC (U16 and U33) was identical and possessed the HLA-A2 binding motif (data not shown) (20) (21) (22) . There was one nucleotidesubstitution (A-+T) at the 5171 position of the HTLV-I gene as compared with the nucleotides reported by Seiki et al. (20) .
The vast majority of HTLV-I provirus+ TCC tested expressed all gag p19 (Table I) , gag p24, env gp46, env gp2l, and tax p40 proteins (data not shown), as determined using a relevant mAb and immunofluorescence technique. One representative histogram of env gp46 protein (Fig. 2 A) and a picture of a gag p19 positive TCC in cytoplasm taken by a confocal laser scanning microscope (Fig. 2 B) are shown. It is important to note that a CD3+ CD4-CD8+ TCC (P7) expressed gag p24, gag p19, and tax p40 but not env gp46 or env gp2l protein.
In contrast, none of these proteins were observed in HTLV-I provirus-TCC (Table I) .
Detection ofHTLV-I virus particles. One HTLV-I-infected TCC (U16) was provided for electron microscopic analysis to detect HTLV-I virus particles. Virus particles characteristic of HTLV-I virus reported by Poiesz et al. (1) and by Hinuma et al. (2) were observed on the cell surface of the U16 clones (Fig.  3) . Multiple particles were observed on 2-3% of the U16 clones (Fig. 3 A) . Several particles were observed on 10-15% of the U16 clones (Fig. 3 B) . The average diameter of the 21 intact particles observed was 102.7 nm.
Cytokine production. IL-6 and TNF-a production was measured in the culture supernatants from 9 (5 HTLV-I+ and 4 HTLV-I-, patient 1) or 24 (14 HTLV-I+ and 10 HTLV-I-, patient 2) TCC (Table I ). All HTLV-I-infected TCC produced greater amounts (235-4,002 pg/ml) of IL-6, and the mean±SD (n = 19) was 1,336±1,050 pg/ml (P < 0.002 versus that by HTLV-I negative TCC). In contrast, HTLV-I negative TCC produced either undetectable levels (< 5 pg/ml, 5 clones) or very low levels (5-68 pg/ml, 9 clones) of IL-6. HTLV-I-in- 266  279  533  107  97  186  521  773  413  <5  <5  <5  <5  40  <5  <5   240  <5  6  115 HTLV-I provirus+ (n = 19) or provirus-TCC (n = 14) established from aqueous or vitreous humor or PBMC were tested for their expression of gag p19 protein using anti-pl9 mAb and immunofluorescent technique. These TCC (1 x 106 cells/ml) were incubated with RPMI 1640 medium plus 10% FCS alone for 20 h in the absence of any stimuli. Cell-free supernatants were measured for IL-6 and TNF-a activity using ELISA kits. The limits of sensitivity were 5 pg/ml. For the statistical analysis (an unpaired t test), the values <5 pg/ml were calculated as 5 pg/ml. * Percentage of positive cells. t Not tested. § Surface marker of P7 clone was CD3+ CD4-CD8+, while that of the other clones was CD3+ CD4+ CD8-.
fected TCC also produced TNF-a, ranging from 8 to 773 pg/ ml, and the mean±SD (n = 17) was 282±245 pg/ml (P < 0.02 versus that by HTLV-I negative TCC) (Table I ). In contrast, 7 out of the 10 HTLV-I negative TCC produced undetectable levels (< 5 pg/ml) of TNF-a, and the others produced lower levels (6, 40 , and 115 pg/ml) of TNF-a.
HTLV-I-infected TCC established from the ocular fluid A. .8:S also produced significant amounts of various cytokines in the absenCe of any stimuli (Table II) . The mean values of cytokines produced by 5 HTLV-I-infected TCC were as follows: 12,699 pg/ml IL-la, 61 pg/ml IL-2, 428 pg/ml IL-3, 8,358 pg/ml IL-6, 1,268 pg/ml IL-8, 28 pg/ml IL-10, 272 pg/ml TNF-a, 5,095 pg/ml IFN-y, and 2,886 pg/ml GM-CSF. In contrast, no TCC produced detectable levels (> 3 pg/ml ) of IL-4. Hydrocortisone, a drug used for the treatment of HTLV-I uveitis, severely suppressed the constitutive production of ILla, IL-3, IL-6 (P < 0.05), IL-8, IL-10, TNF-a, and IFN--y (P < 0.02) (Table II) . It did not inhibit the production of GM-CSF, but slightly increased IL-2 production (P < 0.05) instead. 
Discussion
This study focused primarily on detection of HTLV-I-infected T cells of the eye in patients with HTLV-I uveitis. HTLV-I proviral DNA was identified in 55 out of 94 (59%) TCC (10 out of 34 from aqueous humor and 45 out of 60 from vitreous humor of the 2 patients with HTLV-I uveitis). The majority of TCC had a CD3' CD4' CD8-phenotype, and each TCC used a single T cell receptor a usage as reported elsewhere (13) . Using these TCC, HTLV-I infection was demonstrated by analyzing gene expression at the mRNA level, nucleotide sequence, virus-associated proteins, and virus particles. Therefore, the (13) . These results suggest a possibility that large numbers of HTLV-I-infected T cells cross the blood ocular barrier, rather than a possibility that a single HTLV-Iinfected T cell crosses the barrier and proliferates in the eye at the clonal level. However, the mechanisms by which HTLV-I-infected T cells accumulate in the eye are unknown and should be investigated in the future.
Secondly, this study focused on the involvement of cytokines produced by HTLV-I-infected T cells in intraocular inflammation. HTLV-I-infected TCC, but not HTLV-I negative TCC, from the patients with HTLV-I uveitis constitutively produced IL-la, LL-2, IL-3, IL-6, IL-8, IL-10, IFN-y, TNF-a, and GM-CSF in the absence of any stimuli. They are potent cytokines capable of inducing immune reactions and inflammation at the tissue level (23) (24) (25) (26) (27) (28) (29) (30) . T cells transformed by HTLV-I have been reported to induce and secrete a variety of cytokines including IL-1, IL-2, IL-3, IL-6, TNF, and IFN-y (31-34). In particular, 11L-6 is a typical multifunctional cytokine with numerous biological activities, including hemopoiesis and acute phase responses (23, 26, 30 ). TNF-a appears to be responsible for the pathogenesis of vasculitis in addition to its numerous biological activities (24, 25, 28) .
Hydrocortisone was effective in suppressing the production of all the cytokines produced by these HTLV-I-infected TCC except GM-CSF and 11L-2. This finding was in agreement with our clinical experience reported previously (8, 9) . Namely, systemic or topical administration of corticosteroids was markedly effective in treating intraocular inflammation of HTLV-I uveitis.
In summary, these studies detected HTLV-I proteins and virus particles in T cells from intraocular inflammatory lesion of patients with HTLV-I uveitis. Cytokines constitutively produced by HTLV-I-infected T cells are thought to be responsible for the pathogenesis of HTLV-I uveitis.
